Feedback / Questions
Columvi (glofitamab-gxbm) - Roche
Polivy (polatuzumab vedotin-piiq) - Roche
Columvi + Polivy: Regulatory submissions in US/EU for 1L DLBCL in combination with R-CHP in 2027
(Roche)
-
Oct 22, 2026 -
Q3 2026 Results
EMA filing • FDA filing
•
Diffuse Large B Cell Lymphoma • Hematological Malignancies • Oncology
https://assets.roche.com/f/176343/x/214d9ddfff/irp261022.pdf
Oct 22, 2026
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious